Dimensions

PlumX

Cómo citar
Jim, H., Barata, A., Wenham, R., & Jacobsen, P. (2013). Fatiga, Ánimo y Sueño Durante La Quimioterapia Intraperitoneal: un Estudio Caso-Control Piloto. International Journal of Psychological Research, 6(1), 8–14. https://doi.org/10.21500/20112084.694
Términos de licencia
The work that is sent to this journal must be original, not published or sent to be published elsewhere; and if it is accepted for publication, authors will agree to transfer copyright to International Journal of Psychological Research. 

To give up copyright, the authors allow that, International Journal of Psychological Research, distribute the work more broadly, check for the reuse by others and take care of the necessary procedures for the registration and administration of copyright; at the same time, our editorial board represents the interests of the author and allows authors to re-use his work in various forms. In response to the above, authors transfer copyright to the journal, International Journal of Psychological Research. This transfer does not imply other rights which are not those of authorship (for example those that concern about patents). Likewise, preserves the authors rights to use the work integral or partially in lectures, books and courses, as well as make copies for educational purposes. Finally, the authors may use freely the tables and figures in its future work, wherever make explicit reference to the previous publication in International Journal of Psychological Research. The assignment of copyright includes both virtual rights and forms of the article to allow the editorial to disseminate the work in the manner which it deems appropriate. 

The editorial board reserves the right of amendments deemed necessary in the application of the rules of publication.

Resumen

El estudio comparó cambios longitudinales en fatiga, síntomas depresivos, sueño y actividad en mujeres con cáncer de ovario (n=10) en tratamiento con quimioterapia intraperitoneal (IP) versus intravenosa (IV). Se evaluó la fatiga y los síntomas depresivos (autoreferidos), y el sueño y la actividad (actigrafia) la semana antes y la posterior a la primera infusión. Ambos grupos refirieron mayor fatiga y síntomas depresivos, disminución del sueño, de la actividad diaria y de los patrones de ritmicidad sueño/actividad (p<.05). Las comparaciones entre el grupo IP (ds = -.15 to -8.03) y el grupo IV (ds = .12 to 1.40), y las comparaciones entre-grupos revelaron que los síntomas eran más graves en los pacientes IP (p<.10). Los datos obtenidos sugieren que los pacientes IP experimentan mayor incremento en fatiga, síntomas depresivos y alteraciones del sueño y la actividad en comparación con los pacientes IV.

Palabras clave:

Referencias

Alberts, D. S., Liu, P. Y., Hannigan, E .V., O'Toole, R., Williams, S. D., Young, J. A,.…Malviya,V. K. (1996). Intraperitoneal cisplatin plus intraneous cyclophosphamide for stage III ovarian cancer. The New England Journal of
Medicine, 335(26), 1950-1955.
Alberts, D. S., Markman, M., Muggia, F., Ozols, R. F., Eldermire, E., Bookman, M. A. … Trimble E. (2006). Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer. Gynecologic Oncology, 103(3), 783-792.
Anderson, N. J. & Hacker E. D. (2008). Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: a review of contributing factors. Clinical Journal of Oncology Nursing, 12(3), 445-454.
Andresen, E. M., Malmgren, J. A., Carter, W. B. & Patrick, D. L. (1994). Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). American Journal of Preventive Medicine, 10(2), 77-84.
Armstrong, D. K., Bundy, B., Wenzel, L., Huang, H. Q., Baergen, R., Lele, S. … Gynecologic Oncology Group. (2006). Intraperitoneal cisplatin and paclitaxel in ovarian cancer. The New England Journal of Medicine, 354(1), 34-43.
Armstrong, D. K. & Brady M. F. (2006). Intraperitoneal therapy for ovarian cancer: a treatment ready for prime time. Journal of Clinical Oncology, 24(28), 4531-4533.
Berger, A. M., Wielgus, K. K., Young-McCaughan, S., Fischer, P., Farr, L. & Lee, K. A. (2008). Methodological challenges when using actigraphy in research. Journal of Pain and Symptom Management, 36(2), 191-199.
Berger, A. M., Abernethy, A., Atkinson, A., Barsevick, A., Breitbart, W. S., Cella, D. … Wagner, L. L. (2009). NCCN Clinical Practice Guidelines in Oncology: Cancer-Related Fatigue Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
Cohen, J. (1988) Statistical power for the behavioral sciences. Hillsdale, NJ: Lawrence Erlbaum Associates.
Elit, L., Oliver, T. K., Covens, A., Kwon, J., Fung, M. F., Hirte, H. W. & Oza, A. M. (2007). Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer: a systematic review with metaanalyses. Cancer, 109(4), 692-702.
Frost, M. H., Bonomi, A. E., Cappelleri, J. C., Schünemann, H. J., Moynihan, T. J., Aaronson, N. K., & Clinical Significance Consensus Meeting Group. (2007). Applying quality-of-life data formally and systematically into clinical practice. Mayo Clinic Proceedings, 82(10), 1214-1228.
Gore, M., Du Bois, A. & Vergote, I. (2006). Intraperitoneal chemotherapy in ovarian cancer remains experimental. Journal of Clinical Oncology, 24(28), 4528-4530.
Hann, D. M., Jacobsen, P. B., Azzarello, L. M., Martin, S. C., Curran, S. L., Fields, K. K. … Lyman G. (1998). Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory. Quality of Life Research, 7(4) 301-310.

Descargas

Los datos de descargas todavía no están disponibles.

Citado por